Krish S Krishnan Krystal Biotech, Inc. (KRYS) insider trading activity

KRYS Quotes by TradingView

Krish S Krishnan is President and CEO of Krystal Biotech, Inc.. Currently has a direct ownership of 1.56 Million shares of KRYS, which is worth approximately $270 Million. The most recent transaction as insider was on Sep 12, 2024, when has been sold 25,000 shares (Common Stock) at a price of $198.48 per share, resulting in proceeds of $4,962,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.56M
1.58% 3M change
5.85% 12M change
Total Value Held $270 Million

Krish S Krishnan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 12 2024
SELL
Open market or private sale
$4,962,000 $198.48 p/Share
25,000 Reduced 1.58%
1,562,262 Common Stock
Jun 11 2024
SELL
Open market or private sale
$4,376,500 $175.06 p/Share
25,000 Reduced 1.55%
1,587,262 Common Stock
Mar 11 2024
SELL
Open market or private sale
$4,276,000 $171.04 p/Share
25,000 Reduced 1.53%
1,612,262 Common Stock
Feb 28 2024
SELL
Payment of exercise price or tax liability
$943,417 $163.08 p/Share
5,785 Reduced 0.35%
1,637,262 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
12,500 Added 0.76%
1,643,047 Common Stock
Feb 26 2024
SELL
Payment of exercise price or tax liability
$595,187 $157.0 p/Share
3,791 Reduced 0.23%
1,630,547 Common Stock
Dec 11 2023
SELL
Open market or private sale
$2,648,000 $105.92 p/Share
25,000 Reduced 1.51%
1,634,338 Common Stock
Sep 11 2023
SELL
Open market or private sale
$3,180,250 $127.21 p/Share
25,000 Reduced 1.48%
1,659,338 Common Stock
May 31 2023
SELL
Open market or private sale
$2,921,250 $116.85 p/Share
25,000 Reduced 1.46%
1,684,338 Common Stock
Apr 17 2023
SELL
Open market or private sale
$2,186,500 $87.46 p/Share
25,000 Reduced 1.44%
1,709,338 Common Stock
Feb 26 2023
SELL
Payment of exercise price or tax liability
$341,301 $78.46 p/Share
4,350 Reduced 0.25%
1,734,338 Common Stock
Jan 18 2023
SELL
Open market or private sale
$231,358 $81.15 p/Share
2,851 Reduced 0.16%
1,738,688 Common Stock
Jan 17 2023
SELL
Open market or private sale
$1,807,579 $81.61 p/Share
22,149 Reduced 1.26%
1,741,539 Common Stock
Jan 04 2023
SELL
Open market or private sale
$300,139 $80.08 p/Share
3,748 Reduced 0.21%
1,763,688 Common Stock
Jan 03 2023
SELL
Open market or private sale
$136,561 $80.33 p/Share
1,700 Reduced 0.1%
1,767,436 Common Stock
Dec 29 2022
SELL
Open market or private sale
$646,407 $80.7 p/Share
8,010 Reduced 0.45%
1,769,136 Common Stock
Dec 16 2022
SELL
Open market or private sale
$846,817 $80.1 p/Share
10,572 Reduced 0.59%
1,777,146 Common Stock
Nov 23 2022
SELL
Open market or private sale
$320 $80.01 p/Share
4 Reduced 0.0%
1,787,718 Common Stock
Nov 08 2022
SELL
Open market or private sale
$77,328 $80.05 p/Share
966 Reduced 0.05%
1,787,722 Common Stock
Aug 05 2022
SELL
Open market or private sale
$2,033,750 $81.35 p/Share
25,000 Reduced 1.38%
1,788,688 Common Stock
Feb 26 2022
SELL
Payment of exercise price or tax liability
$290,938 $62.5 p/Share
4,655 Reduced 0.26%
1,813,688 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
-
40,800 Added 2.07%
1,927,262 Common Stock
KSK

Krish S Krishnan

President and CEO
Pittsburgh, PA

Track Institutional and Insider Activities on KRYS

Follow Krystal Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRYS shares.

Notify only if

Insider Trading

Get notified when an Krystal Biotech, Inc. insider buys or sells KRYS shares.

Notify only if

News

Receive news related to Krystal Biotech, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRYS